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Abstract
Strategies to identify and mitigate publication bias and outcome reporting bias are fre-
quently adopted in systematic reviews of clinical interventions but it is not clear how often
these are applied in systematic reviews relating to quantitative health services and delivery
research (HSDR). We examined whether these biases are mentioned and/or otherwise
assessed in HSDR systematic reviews, and evaluated associating factors to inform future
practice. We randomly selected 200 quantitative HSDR systematic reviews published in
the English language from 2007–2017 from the Health Systems Evidence database
(www.healthsystemsevidence.org). We extracted data on factors that may influence
whether or not authors mention and/or assess publication bias or outcome reporting bias.
We found that 43% (n = 85) of the reviews mentioned publication bias and 10% (n = 19)
formally assessed it. Outcome reporting bias was mentioned and assessed in 17% (n =
34) of all the systematic reviews. Insufficient number of studies, heterogeneity and lack of
pre-registered protocols were the most commonly reported impediments to assessing the
biases. In multivariable logistic regression models, both mentioning and formal assess-
ment of publication bias were associated with: inclusion of a meta-analysis; being a review
of intervention rather than association studies; higher journal impact factor, and; reporting
the use of systematic review guidelines. Assessment of outcome reporting bias was asso-
ciated with: being an intervention review; authors reporting the use of Grading of Recom-
mendations, Assessment, Development and Evaluations (GRADE), and; inclusion of only
controlled trials. Publication bias and outcome reporting bias are infrequently assessed in
HSDR systematic reviews. This may reflect the inherent heterogeneity of HSDR evidence
and different methodological approaches to synthesising the evidence, lack of awareness
of such biases, limits of current tools and lack of pre-registered study protocols for assess-
ing such biases. Strategies to help raise awareness of the biases, and methods to
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minimise their occurrence and mitigate their impacts on HSDR systematic reviews, are
needed.
Introduction
Health services and delivery research (HSDR) can be defined as “research that is used to pro-
duce evidence on the quality, accessibility and organisation of health services including evalua-
tion of how healthcare organisations might improve the delivery of services” [1]. Whilst
clinical research into understanding biochemical mechanisms of diseases and their treatments
has to some extent dominated health research, the importance of HSDR is increasingly being
recognised [2]. For example, a study examining research grants that could impact upon child-
hood mortality in low-income countries found that 97% of grants were allocated to developing
new health technologies, leading to a potential reduction in child death of about 22%, com-
pared to a potential reduction of 63% from research aimed at improving the delivery and utili-
zation of existing technologies [3]. Such finding suggests that while there is a need for research
on effective treatments, there is arguably an even greater need for research on the delivery sys-
tems that support front line care [4]. With increasing recognition of the importance of HSDR
has come increased scrutiny [5]. As with many other fields of research, systematic reviews
have proven to be an important tool for summarising and synthesising the rapidly expanding
evidence base. The validity of systematic reviews, however, can be undermined by publication
bias, which occurs when the publication or non-publication of research findings is determined
by the direction or strength of the evidence [6], and by outcome reporting bias whereby only a
subset of outcomes, typically those most favourable, are reported [7]. Consequently, the find-
ings that are published (and therefore more likely to be included in systematic reviews) may
differ systematically from those that remain unpublished. This results in a biased summary of
the evidence which in turn can impair decision making. In HSDR, this could have substantial
implications for population health and resource allocation.
To minimise the potential for such biases, mitigating strategies are often included in the pro-
cess of systematic reviewing. These include: comprehensive literature searching including
attempts to locate grey literature or unpublished studies; assessment of outcome reporting bias
of included studies; and assessment of potential publication bias using funnel plots, related
regression methods and/or other techniques [8]. The level of adoption of such strategies in sys-
tematic reviews has been shown to vary by subject area. For example, a study from 2010 which
assessed four categories of systematic review from MEDLINE showed that publication bias was
assessed in 21% of treatment intervention reviews, 24% of diagnostic test accuracy reviews,
31% of reviews focusing on association between risk factors and health outcomes, and 54% of
genetic reviews assessing association between genes and disease [6]. Another study which
examined a random sample of 300 systematic reviews of biomedical research indexed in MED-
LINE in February 2014 found that 31% had formally assessed publication bias [9]. However, a
study examining the reporting characteristics and methodological quality of 99 systematic
reviews of health policy research generated by the Cochrane Effective Practice and Organisa-
tion of Care Review Group prior to 2014 reported that only 9% of the reviews explicitly assessed
publication bias [10]. These findings suggest that the assessment of publication bias is generally
low in systematic reviews of clinical research and may be even lower in HSDR and policy
research. More detailed information from a broader range of reviews is required to better
understand current practice relating to the assessment of publication bias and outcome report-
ing bias in HSDR systematic reviews. Against this background, the objectives of this study are
to examine whether publication bias and outcome reporting bias are mentioned and/or
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assessed in a representative sample of HSDR systematic reviews, and to summarise the methods
adopted as well as findings reported or reasons stated for not formally assessing the biases.
We focus on systematic reviews of quantitative HSDR studies that involve evaluation of
strength and direction of effects, which can be subject to hypothesis testing. Within this broad
category, we sampled two review types:
• Intervention reviews, which aim to evaluate the effectiveness of service delivery interven-
tions. These reviews often include randomised controlled trials (RCTs), other quasi-experi-
mental studies and sometimes uncontrolled before-and-after studies, and
• Association reviews, which evaluate associations between different variables (such as nurse-
patient ratio, frequency of patient monitoring and in-hospital mortality) along the service
delivery causal chain [4]. Association reviews tend to include mostly observational studies.
While intervention reviews usually set out to examine pre-specified causal relationships
between an intervention and designated outcomes, association reviews tend to be exploratory.
Consequently, the characteristics (such as inclusion of meta-analysis, number and design of
included studies, and the use of systematic review guidelines) of these two types of reviews
may differ. We hypothesised that association studies may be more susceptible to publication
and outcome reporting biases than intervention studies due to the exploratory nature of most
association studies. We therefore investigate whether the practice of assessing these biases and
the findings of these assessments differ between HSDR systematic reviews focusing on these
two types of studies. In addition, we examine whether awareness and/or assessment of publica-
tion and outcome reporting biases is associated with factors other than the nature of the
review, such as author’s use and journal’s endorsement of methodological guidelines for the
conduct and reporting of systematic reviews, and journal impact factor [11].
Methods
We carried out a meta-epidemiological study [12] to estimate the frequency with which publi-
cation and outcome reporting bias were considered in systematic reviews and to explore fac-
tors associated with consideration of these forms of potential bias. The review was pre-
registered in the PROSPERO International prospective register of systematic reviews (2016:
CRD42016052366 www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42016052366).
Sampling strategy
Our initial plan for identifying a sample of HSDR systematic reviews specified in the PROS-
PERO registration record was to conduct a literature search by using a combination of different
information sources and searching methods [13]. Retrieved records would subsequently be
screened for eligibility and classified as intervention or association reviews before a random
sample was selected. However, the proposed sampling strategy was subsequently deemed not
feasible given the large number of systematic reviews that would have to be checked for eligibil-
ity before sampling. This is due to the methodological diversity of HSDR-related research and
the absence of universally accepted terms through which to search for HSDR systematic
reviews. We therefore adopted the alternative method of selecting systematic reviews from the
Health Systems Evidence (HSE) database (www.healthsystemsevidence.org) [14]. The HSE is
a continuously updated repository of syntheses of research evidence about the governance,
financial and delivery arrangements within health systems, and the implementation strategies
that can support change in health systems [14]. It covers several databases including Medline
and Cochrane Database of Systematic Reviews. With the help of the owner of the database, we
downloaded all the available citations of systematic reviews indexed in the HSE as of August
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2017 into a Microsoft Excel spreadsheet. The HSE classifies each of the systematic reviews into
two groups based on the type of question the reviews address; ‘effectiveness’ for the systematic
reviews concerned with effects and ‘other questions’. The reviews classed as effectiveness
(n = 4416) served as the sampling frame for the intervention reviews while those classed as ‘oth-
ers’ (n = 1505) were used for the association reviews. In order to facilitate random selection of
reviews, we assigned a random number to each record using the RAND() function in Excel,
sorted the random numbers in ascending order before screening the records for eligibility using
pre-specified criteria, as described below, until the desired number of reviews was identified.
Sample size
We aimed to include 200 systematic reviews in total; 100 reviews of intervention studies and
100 reviews of association studies. This sample size has a statistical power of 80% to detect a
20% difference in the characteristics and findings between the two types of review, assuming a
baseline rate of 32%, based on the proportion of Cochrane EPOC reviews in which publication
bias was formally assessed or for which partial information was given [10].
Eligibility criteria
In this study, a systematic review was defined as any literature review which presents explicit
statements with regard to research question(s), search strategy and criteria for study selection.
We also defined HSDR as research that produces evidence on the quality, accessibility and
organisation of health services based on the definition adopted by the United Kingdom’s
National Institute for Health Research (NIHR) Health Services & Delivery Research Pro-
gramme [1]. Systematic reviews examining quantitative data and relating to any aspects of
HSDR were selected irrespective of whether they included a meta-analysis. To be eligible, the
systematic review had to report at least one quantitative effect estimate or a statistical test
which could be derived from the studies included in the review. Since contemporary literature
are of more relevance to current practice, we included reviews from the last ten years
(between2007 to 2017). We excluded records which were: not systematic reviews; not related
to HSDR; not concerned with interventions or associations; not examining quantitative data;
not published in English language; or were published before the year 2007. We also excluded
systematic reviews that are usually classified as health technology assessment (such as those
investigating effectiveness and cost effectiveness of clinical interventions) and those classified
as clinical or genetic epidemiology (that is, those examining association between risk factors
and disease conditions). Where more than one review within the initially selected samples
cover overlapping interventions or associations, we included the latest review. This helped to
maintain the independence of observations and also capture the contemporary practice.
Sample selection was conducted by one author (AAA) and checked by a second author
(YFC). Discrepancies were resolved by discussion and members of the research project man-
agement team (in the first instance) and steering committee were consulted when the two
authors could not reach an agreement or when generic issues concerning study eligibility crite-
ria were identified.
Data extraction and classification of review characteristics
Data extraction focused on general systematic review characteristics and components that may
influence whether or not authors refer to and/or assess publication bias or outcome reporting
bias. Thus, data extracted from each eligible review included:
• key study question(s)
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• databases searched
• whether an attempt was made to search grey literature and unpublished reports or whether
reasons for not doing this were provided
• design of included studies (whether or not these are confined to controlled trials)
• number of included studies (categorised into <10 and�10 based on the minimum number
of studies recommended for statistical approaches to assessment of publication bias[15])
• Whether meta-analyses were performed
• whether the use of systematic review related guidelines was reported (we assumed that all
Cochrane reviews adhered to the Methodological Expectations of Cochrane Intervention
Reviews (MECIR) standards [16] even if not reported by authors)
• whether the use of Grading of Recommendations, Assessment, Development and Evalua-
tions (GRADE) was reported
• any mentioning of publication bias and/or outcome reporting bias
• methods (if used at all) for assessing potential publication bias and/or outcome reporting bias
• findings of assessment of publication bias and/or outcome reporting bias or reasons for not
formally assessing these
We planned to categorise the types of journals in which the systematic reviews were pub-
lished based on subject categories of the Journal Citation Reports (ISI Web of Knowledge,
Thomson Reuters) as medical journals, health services research and health policy journals,
management and social science journals or others(including grey literature), but discovered
substantial overlap in the features between journal types which hindered reliable classification
of some journals and in turn would cause difficulty in the interpretation of observations made
based on the classification. We discussed this issue with the study steering committee mem-
bers, who suggested us to use journal endorsement of systematic review guidelines and journal
impact factors to characterise the journals instead.
Some journals/media require submitted systematic reviews to follow specific systematic
review guidelines, for example, PRISMA statement [17], MOOSE checklist [18], MECIR stan-
dards (for Cochrane reviews) [16]. Such guidelines includes items on publication bias and may
prompt reviewers to consider publication bias, particularly at the manuscript preparation
stage. Based on the information available on journal websites, we categorised the journal/
media in which the systematic reviews were published into those which formally endorse spe-
cific systematic review guidelines and those that do not (as of year 2018). Targeting prestigious
journals for publication may also prompt reviewers to be more rigorous and so we identified
the five year impact factors (as of year 2016) for the journal each review was published in from
ISI Web of Knowledge, Thomson Reuters. When impact factor was not available on the Web
of Knowledge website, it was obtained from other sources such as directly from the journal
website. We imputed an impact factor of zero for journals with no impact factors and grey lit-
erature (such as theses). One author carried out all the data extraction and the data was inde-
pendently checked by another author. Any discrepancies were resolved by discussion.
Quality assessment of included systematic reviews
Each systematic review included in the HSE was assessed independently by two reviewers
using the Assessing the Methodological Quality of Systematic Reviews (AMSTAR) and the
score was provided within the record for each review [19]. However, five of the selected
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systematic reviews had missing AMSTAR scores so two authors independently carried out the
quality assessment for them using the same version of the AMSTAR tool as the remaining 195
systematic reviews. Discrepancies were resolved by discussion. Percentage AMSTAR scores
were computed for each review taking into account the number of items (the denominator)
that was applicable to individual reviews.
Statistical analysis
Descriptive statistics were used to summarise the characteristics of the selected HSDR system-
atic reviews, the practice of assessing publication bias and outcome reporting bias among the
reviews, and their findings. Differences between association reviews and intervention reviews
were explored. We presented confidence intervals to indicate the levels of uncertainty but
avoided quoting p values and inferring to statistical significance given the descriptive nature of
the study and the large number of exploratory comparisons made.
Three measures related to the awareness and actual practice of assessing publication and
outcome reporting biases were evaluated:
1. “mentioned publication bias”, that is, authors included statements related to publication
bias in their report regardless of whether or not this was accompanied by formal assessment
(with explicitly stated methods, e.g. use of funnel plots or comparison with findings from
search of study registries known to capture all related studies that have been conducted; the
latter is unlikely to be feasible in HSDR);
2. “assessed publication bias”, which includes only those reviews where publication bias was
formally assessed, and
3. “assessed outcome reporting bias” where authors have assessed outcome reporting bias.
Univariable and multivariable logistic regressions were used to explore review and journal
characteristics associated with mentioning/assessment of publication bias and outcome report-
ing bias in the reviews. The strength of association between these variables and practice of bias
assessment was presented as an odds ratio (OR) with 95% confidence intervals.
Results
Sampling of HSDR systematic reviews from HSE
We screened 220 of the 4416 systematic reviews classified as ‘systematic reviews of effects’ in
the HSE to obtain 100 eligible systematic reviews of intervention for this study. Reviews were
excluded mainly because their topics fell outside our definition of HSDR, such as those consid-
ered as public health research and health technology assessments. We screen all 1505 system-
atic reviews classified as ‘systematic reviews addressing other questions’ to identify 100 eligible
systematic reviews of association for this study. Reviews were excluded because the topics
under review fell outside our definitions of HSDR and association studies, and/or because
their designs did not include a quantitative component, such as reviews adopting narrative
and qualitative synthesis approaches and scoping reviews.
Characteristics of included intervention and association reviews
The characteristics of the included systematic reviews (100 intervention reviews and 100 asso-
ciation reviews) are shown in Table 1. The majority of the 200 systematic reviews (79%)
included at least ten studies but less than a quarter (22%) included a meta-analysis. Ninety of
the reviews that did not include meta-analysis provided reasons for this–mainly small number
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of comparable studies and high heterogeneity between studies. Searches of grey/unpublished
literature were conducted in 52% of the systematic reviews. Quality assessment of individual
studies was performed in 79% of the systematic reviews but only 12% reported using GRADE
for assessing the overall quality of evidence. The systematic reviews were of moderate quality
with median AMSTAR score of 60% (IQR 44% to 73%). Many of the systematic reviews (70%)
were published in journals which endorse PRISMA, although the use of such guidelines were
only reported in 37% of them.
We observed notable differences between intervention and association reviews in many of
the characteristics assessed. For example, intervention reviews were more likely to: include
meta-analysis, inclusion of only controlled trials, carry out quality assessment of included
studies, report the use of systematic review reporting guidelines and GRADE, have higher
AMSTAR ratings and be published in journals with higher impact factors (Table 1). Con-
versely, association reviews were more likely to include ten or more studies compared with
intervention reviews (86% vs 71%). Only the search of grey literature and being published in
journal which endorse systematic review guideline were similar in both intervention and asso-
ciation reviews.
Publication bias
Eighty-five (43%) of the systematic reviews mentioned publication bias and these included a
higher proportion of intervention reviews than association reviews (54% vs 31%). Only about
10% (n = 19/200) formally assessed publication bias through statistical analysis, mostly using
funnel plots and related methods. Again, intervention reviews assessed publication bias more
frequently compared to association reviews (14% vs 5%; Table 1). Some evidence of publica-
tion bias (strictly speaking, evidence of small study effects in most instances) was reported in
Table 1. Characteristics of included reviews and comparison between association and intervention reviews.
All [n (%)] Association [%] Intervention [%] Difference a (%)
Characteristics n = 200 n = 100 n = 100 (95% CI)
Number of included studies (�10) 157 (79%) 86 71 15 (4 to 26)
Meta-analysis included 43 (22%) 10 33 -23 (-34 to -12)
Included only RCT and controlled trials 36 (18%) 1b 35 -34 (-44 to -24)
Searched grey/unpublished literature 103 (52%) 52 51 1 (-13 to 15)
Quality assessment performed 157 (79%) 70 87 -17 (-28 to -6)
Authors reported using GRADE 23 (12%) 6 17 -11 (-20 to -2)
Authors reported using systematic review reporting guideline 73 (37%) 28 45 -17 (-30 to -4)
Percentage of positive AMSTAR rating [median (IQR)] 60% (44%, 73%) 50% (40%, 65%) 65% (50%, 82%) -14 (-20 to -10)c
Journal impact factor in year 2016 [median (IQR)] 3.00 (2.26, 5.10) 2.66 (2.07, 3.39) 3.55 (2.30, 7.08) -0.98 (-1.73, -.35)c
Journal endorses systematic review guideline (as of year 2018) 140 (70%) 69 71 -2 (-15, 11)
Publication bias mentioned or assessed 85 (43%) 31 54 -23 (-36, -10)
Publication bias assessed 19 (10%) 5 14 -9 (-17, -1)
Outcome reporting bias mentioned and assessed 34 (17%) 4 30 -26 (-16, -36)
Mentioned or assessed publication bias and/or outcome reporting bias 95 (48%) 32 63 -31 (-44, -18)
Assessed publication bias and/or outcome reporting bias 49 (24.5%) 9 40 -31 (-42, -20)
a Comparison between association and intervention reviews
b The systematic review was a meta-regression analysis of randomised controlled trials that focused on identifying factors associated with effective computerised clinical
decision support systems.
c Hodges-Lehmann difference between medians with 95% CI
https://doi.org/10.1371/journal.pone.0227580.t001
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five (26%) of the reviews which assessed publication bias. The remaining reviews mostly
reported low/no risk of publication bias. One review, which included four studies, constructed
a funnel plot but reported that it was not very informative due to small numbers [20]. In five of
the systematic reviews, authors reported planning statistical assessment of publication bias but
did not carry out the assessment due to the conditions of using funnel plots not being met,
especially insufficient number of studies and/or heterogeneity between included studies.
[21–25]
Factors associated with mentioning (including assessing) publication bias. In the uni-
variable analysis, publication bias was more likely to be mentioned in intervention reviews
when compared to association reviews (OR 2.61, 95% CI 1.47–4.66). Reviews which included
meta-analysis were more than five times more likely to mention publication bias compared to
those with no meta-analysis (OR 5.71, 95% CI 2.67–12.21). Mentioning publication bias
appeared to be associated with quality assessment of individual studies, authors reporting the
use of GRADE, journal impact factor, and authors reporting the use of systematic review
guideline (Table 2). Most of the apparent associations attenuated in the multivariable analysis,
indicating some levels of interaction between these factors. Inclusion of meta-analysis
remained strongly associated with mentioning publication bias (Table 2).
Factors associated with assessing publication bias. Intervention reviews were again
more likely to include an assessment of publication bias than association reviews (OR 3.09,
95% CI 1.07–8.95). Of all factors assessed, inclusion of meta-analysis was the factor most
strongly associated with assessment of publication bias (OR 112.32, 95% CI 14.35–879.03) in
the univariable analysis. Only one of the 19 systematic reviews which assessed publication bias
did not carry out a meta-analysis. Assessment of publication bias also appeared to be associ-
ated with the inclusion of only RCTs and controlled trials, journal impact factor and authors
reporting the use of systematic review guidelines (Table 3). Other factors including number of
included studies, search of grey/unpublished literature, quality assessment of individual studies
and journal endorsement of systematic review guidelines were not significantly associated
with assessment of publication bias. In the multivariable analysis, the pattern of apparent asso-
ciations largely remained the same, although the relationship between assessment of publica-
tion bias and two of the factors (types of review and journal impact factors) diminished after
adjusting for other factors (Table 3).
Table 2. Factors associated with mentioning publication bias.
Mentioned publication bias
Factor All (n = 200) [n
(%)]
Yes (n = 85) [n
(%)]
No (n = 115) [n
(%)]
Univariable OR (95%
CI)
Multivariable OR (95%
CI)
Being an intervention (versus association) review 100 (50%) 54 (64%) 46 (40%) 2.61 (1.47–4.66) 1.63 (0.85–3.15)
Number of included studies 157 (79%) 66 (78%) 91 (79%) 0.92 (0.46–1.81) 1.16 (0.53–2.53)
Meta-analysis included 43 (22%) 32 (38%) 11 (10%) 5.71 (2.67–12.21) 4.02 (1.76–9.15)
Included only RCT & controlled trials a 36 (18%) 20 (24%) 16 (14%) 1.90 (0.92–3.94)
Searched grey/unpublished literature 103 (52%) 46 (54%) 57 (50%) 1.20 (0.68–2.10) 1.16 (0.60–2.23)
Quality assessment performed 157 (79%) 75 (88%) 82 (71%) 3.02 (1.39–6.54) 2.08 (0.88–4.90)
Authors reported using GRADE 23 (12%) 15 (18%) 8 (7%) 2.87 (1.15–7.12) 1.58 (0.57–4.44)
Authors reported using a systematic review guideline 73 (37%) 40 (47%) 33 (29%) 2.21 (1.23–3.97) 1.35 (0.68–2.70)
Journal impact factor in the year 2016 [median (IQR)] 3.00 (2.26, 5.10) 3.26 (2.27–6.01) 2.74 (2.18–4.29) 1.11 (1.02–1.22) 1.04 (0.96–1.15)
Journal endorses a systematic review guideline (as of
the year 2018)
140 (70%) 61 (72%) 79 (69%) 1.16 (0.67–2.14) 0.94 (0.46–1.93)
a Not included in multivariable analysis as this factor is strongly correlated with review type (intervention vs association)
https://doi.org/10.1371/journal.pone.0227580.t002
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Outcome reporting bias
Thirty-four (17%) of all the systematic reviews mentioned and assessed outcome reporting
bias as part of quality assessment of included studies. None of the systematic reviews men-
tioned outcome reporting bias without assessing it. Again this was more frequent in interven-
tion reviews than in association reviews (30% vs 4%). The majority of the reviews which
assessed outcome reporting bias used the Cochrane risk of bias tool (n = 28/34) [26]. Two
reviews used the Agency for Healthcare Research and Quality’s (AHRQ’s) Methods Guide for
Effectiveness and Comparative Effectiveness Reviews [27], one used the Amsterdam-Maas-
tricht Consensus List for Quality Assessment, while the remaining three reviews used unspeci-
fied or bespoke tools. Of the 34 reviews which assessed outcome reporting bias, 31 reported
the findings, while the remaining three did not report the findings despite having reported
assessing the bias in the methods section. Of the 31 reviews which reported the findings, 35%
(n = 11/31) identified at least one study with high risk of selective outcome reporting, 32%
(n = 10/31) judged all included studies to be low risk while the remaining 10 reviews (32%)
had at least one study where the authors were unable to judge the risk of bias and were classed
as ‘unclear’. In three reviews, lack of pre-registered protocols was reported as the reason for
judging articles as ‘unclear’.[20, 22, 28] In a review in which the review authors explicitly stated
that they did not search for study protocols, 13 out of the 19 studies included in the review was
judged as ‘unclear’ with regard to selective outcome reporting.[29]
Factors associated with assessing outcome reporting bias. Intervention reviews were
about ten times as likely to include an assessment of outcome reporting bias compared to asso-
ciation reviews (OR 10.29, 95% CI 3.47–30.53). Assessment of outcome reporting bias was also
strongly associated with authors reporting the use of GRADE (OR 9.66, 95% CI 3.77–24.77)
and inclusion of RCTs or controlled trials only (OR 7.74, 95% CI 3.39–17.75). Number of
included studies, inclusion of meta-analysis, journal impact factor, journal endorsement of
systematic review reporting guidelines and authors reporting the use of systematic review
guidelines also appeared to be associated with the assessment of outcome reporting bias
(Table 4). The variable relating to quality assessment of individual studies was not included in
the regression analysis because all studies which assessed outcome reporting bias performed
quality assessment of individual studies. Two variables remained strongly associated with
Table 3. Factors associated with the assessment of publication bias.
Assessed Publication bias
Factor All (n = 200) [n
(%)]
Yes (n = 19) [n
(%)]
No (n = 181) [n
(%)]
Univariable OR (95%
CI)
Multivariable
Being an intervention review (versus association review) 100 (50%) 14 (74%) 86 (48%) 3.09 (1.07–8.95) 0.94 (0.20–4.55)
Number of included studies (�10) 157 (79%) 17 (90%) 140 (77%) 2.49 (0.55–11.22) 2.21 (0.32–15.27)
Meta-analysis included 43 (22%) 18 (95%) 25 (14%) 112.32 (14.35–879.03) 84.65 (9.56–
749.49)
Included only RCT and controlled trials a 36 (18%) 7 (37%) 29 (16%) 3.06 (1.11–8.42)
Searched grey/unpublished literature 103 (52%) 6 (32%) 97 (54%) 0.40 (0.15–1.10) 0.34 (0.08–1.46)
Quality assessment performed 157 (79%) 18 (95%) 139 (77%) 5.44 (0.71–41.96) 5.29 (0.38–82.82)
Authors reported using GRADE 23 (12%) 2 (11%) 21 (12%) 0.90 (0.19–4.16) 0.47 (0.07–3.38)
Authors reported using systematic review guideline 73 (37%) 14 (74%) 59 (33%) 5.79 (1.99–16.84) 5.38 (1.19–24.23)
Journal impact factor in the year 2016 [median (IQR)] 3.00 (2.26,5.10) 3.85 (2.73,5.76) 2.94 (2.14,4.98) 1.09 (1.004–1.18) 1.01 (0.90–1.13)
Journal endorses systematic review guideline (as of the
year 2018)
140 (70%) 10 (53%) 130 (72%) 0.44 (0.17–1.34) 0.22 (0.04–1.09)
a Not included in multivariable analysis as this factor is strongly correlated with review type (intervention vs association)
https://doi.org/10.1371/journal.pone.0227580.t003
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assessing outcome reporting bias in the multivariable analysis: author reporting the use of
GRADE and being an intervention review (Table 4).
Discussion
We obtained a random sample of 200 quantitative systematic reviews in HSDR and examined
their characteristics in relation to assessment of publication bias and outcome reporting bias.
Only 10% of the systematic reviews formally assessed publication bias even though 43% men-
tioned publication bias. The majority of the systematic reviews (83%) neither mentioned nor
assessed outcome reporting bias. A higher proportion of the intervention reviews mentioned
and assessed both biases compared to the association reviews.
Strengths and limitations
One of the strengths of the current study is that a broad range of quantitative HSDR systematic
reviews was examined. The HSE database, from which the systematic reviews were selected,
covers multiple sources of literature, and our selection was neither limited to a single source of
literature nor restricted to highly ranked journals as was the case in previous studies.[30–32]
Also, study selection and data extraction were carried out by one person and checked by
another in order to ensure accuracy and completeness.
We targeted intervention and association reviews with a quantitative component in HSDR
as defined earlier in this paper. The concept of intervention reviews matched well with the
category of ‘systematic reviews of effects’ in the HSE database where we drew our sample.
However, clearly delineating association reviews and identifying those incorporating some
quantitative components have proven challenging. We had to screening more than a thousand
records classified as ‘systematic reviews addressing other questions’ in the HSE to obtain our
required sample, as the majority of reviews in this category either adopted descriptive, narra-
tive or qualitative approaches, or did not match our definition of an HSDR association review.
We ensured that we only include the latest systematic review whenever we identified more
than one which covers overlapping topics. There may be some overlap in the studies included
Table 4. Factors associated with the assessment of outcome reporting bias.
Assessed outcome reporting bias
Factor All (n = 200) [n
(%)]
Yes (n = 34) [n
(%)]
No (n = 166) [n
(%)]
Univariable OR (95%
CI)
Multivariable
Being an intervention review (versus association review) 100 (50%) 30 (88%) 70 (42%) 10.29 (3.47–30.53) 6.44 (2.01–
20.60)
Number of included studies 157 (79%) 20 (59%) 137 (83%) 0.30 (0.14–0.67) 0.53 (0.20–1.43)
Meta-analysis included 43 (22%) 13 (38%) 30 (18%) 2.81 (1.27–6.23) 1.73 (0.65–4.59)
Included mainly RCT and controlled trials a 36 (18%) 17 (50%) 19 (12%) 7.74 (3.39–17.75)
Searched grey/unpublished literature 103 (52%) 22 (65%) 81 (49%) 1.92 (0.89–4.14) 1.33 (0.51–3.46)
Quality assessment performed b 157 (79%) 34 (100%) 123 (74%)
Authors reported using GRADE 23 (12%) 13 (38%) 10 (6%) 9.66 (3.77–24.77) 5.18 (1.61–
16.67)
Authors reported using systematic review guideline 73 (37%) 22 (65%) 51 (31%) 4.13 (1.90–8.99) 1.97 (0.78–4.99)
Journal impact factor in the year 2016 [median (IQR)] 3.00 (2.26, 5.10) 6.58 (2.63,7.08) 2.77 (2.11,4.28) 1.10 (1.01–1.19) 1.04 (0.95–1.13)
Journal endorses systematic review guideline (as of the
year 2018)
140 (70%) 29 (85%) 111 (67%) 2.87 (1.05–7.83) 1.99 (0.65–6.12)
a Not included in multivariable analysis as this factor is strongly correlated with review type (intervention vs association)
b Not included in regression analyses because all reviews which assessed outcome reporting bias performed quality assessment
https://doi.org/10.1371/journal.pone.0227580.t004
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within different systematic reviews, but we do not believe this would have significant impact
on our findings as our study focuses on the overall features and methodology of the sampled
systematic reviews rather than on individual studies included within them. We not only exam-
ined the proportion of systematic reviews which mentioned/assessed publication bias but also
explored a number of factors which may influence these. Although the sample size of 200
reviews is still relatively small, as evident by the large confidence intervals for the ORs obtained
from the multivariable logistic regression analyses, we were able to identify a few factors that
may influence assessment of publication and outcome reporting bias in HSDR systematic
reviews. We are aware that the variables which we examined may interact in various ways, as
indicated by the changes in the estimated ORs between univariable and multivariable analyses
for some of the variables examined. The relationships between the factors that could impact
upon assessment of publication and outcome reporting bias in HSDR systematic reviews are
intricate and will require further research to clarify.
The association between journal’s endorsement and authors’ use of reporting guidelines
and assessment of publication bias may not have been characterised very accurately in our
study. We classified journals based on endorsement of reporting guidelines as of 2018 but we
were not able to determine if this has been the case as at the time the systematic review authors
prepared/published their manuscripts. Notwithstanding, journal endorsement of such guide-
lines may be an indication of the journal’s generic requirement of higher standard of reporting.
Also, available reporting guidelines are mostly aimed at systematic reviews of intervention
studies and authors of systematic reviews of association studies might not have considered that
it was necessary to follow such guidelines, even if it was endorsed by the journal they published
in. Alternatively, some authors might have used reporting guidelines during the preparation of
their reviews without explicitly stating it.
HSE used AMSTAR to assess the quality of included systematic reviews. We also used the
same tool to assess the quality of the five systematic reviews with missing AMSTAR scores in
order to maintain consistency. However, AMSTAR was designed for quality assessment of
systematic reviews of RCTs of interventions and therefore some of the items were not rele-
vant for many of the systematic reviews in this study. An updated version of the tool,
AMSTAR 2, was published in 2017 which includes items relevant to non-randomised studies
and would have been more appropriate for assessing the qualities of the systematic reviews
included in this study [33]. Another potential limitation of this study is that we only
included systematic reviews of quantitative studies although HSDR involves a wide range of
study design, including qualitative studies. However, we believe issues relating to publica-
tion bias and outcome reporting bias in qualitative research warrants separate investigation
as the mechanisms and manifestation of such biases are likely to be different in qualitative
research.
Explanation of results and implications
Overall, the awareness of publication bias in quantitative HSDR reviews seems comparable to
those reported for reviews in some other fields, although formal assessment of publication bias
is less common especially in association reviews. Table 5 shows that the level of documenting
awareness of publication bias by at least mentioning it was generally low in systematic reviews
examined in previous studies in various fields of biomedical research, with a notable exception
among systematic reviews of genetic association studies in which 70% mentioned publication
bias. Unlike publication bias where many authors did discuss the potential implications even
when they were not able to assess it, outcome reporting bias was only mentioned when it was
assessed. However, mentioning of outcome reporting bias was lower than 30% across the
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board (17% in the current study), with very low rates observed in reviews of HSDR association
studies (4% in the current study) and reviews of epidemiological risk factors (3% [6]).
A number of inter-related issues warrant further consideration when interpreting these
findings and making recommendations. First, the research traditions and nature of evidence
varies between different subject disciplines and may influence the perceived importance and
relevance of considering publication and outcome reporting biases in the review process.
These variations might have contributed to the apparently low prevalence of assessing and
documenting these biases in HSDR reviews and wide variations observed in different disci-
plines. For example, we found that meta-analysis was conducted in only 33% of the HSDR
intervention reviews. This is similar to 39% reported in a previous study of Cochrane reviews
focusing on HSDR (health policy) interventions [10]. We found an even lower prevalence
(10%) of including meta-analysis in HSDR association reviews. These figures are in contrast
with at least 60% observed among both intervention and association reviews in clinical
research (Table 5). There is a general recognition that HSDR requires consideration of multi-
ple factors in complex health systems,[4] and that evidence generated from HSDR tends to be
context-specific.[35–37] It is therefore possible that HSDR systematic reviews which evaluate
intervention effects and associations, and particularly the latter which examine associations
between the myriads of structure, process, outcome measures and contextual factors, may tend
to adopt a more configurative, descriptive approach (as opposed to the more aggregative,
Table 5. Findings from current and previous studies on assessment of publication and outcome reporting biases in systematic reviews of health literature.
Study and nature of systematic reviews
examined
Searched grey literature/
unpublished studies�
Included
meta-analysis
Mentioned
publication bias
Formally assessed
publication bias
Mentioned
outcome reporting
bias
Outcome
reporting bias
assessed
Current review
HSDR Intervention (n = 100) 51% 33% 54% 14% 30% 30%
HSDR association (n = 100) 52% 10% 31% 5% 4% 4%
Li et al. 2015 [10]
Health policy interventions (n = 99)
67% judged to be
comprehensive
39% 32%�� 9% NR NR
Ziai et al. 2017 [30] High-impact clinical
journals (n = 203)
64% NR 61% 33% NR NR
Herrmann et al. 2017 [31]
Clinical oncology (n = 182)
27% conference abstract;
8% trial registries
NR 40% 28% NR NR
Chapman et al. 2017 [32]
High-impact surgical journals (n = 81
pre-PRISMA, n = 201 post-PRISMA)
Pre 71%
Post 90% judged to be
comprehensive
Pre 65%
Post 78%
NR Pre 39%
Post 53%
NR NR
Page et al. 2016 [9] Biomedical literature
(n = 300)
16% conference
abstract;19% trial
registry
63% 47% 31% NR 24% (n = 296)
Song et al. 2010 [6]
Treatment effectiveness (n = 100) 58% 60% 32% 21% 18% NR
Diagnostic accuracy (n = 50) 36% 82% 48% 24% 14% NR
Epidemiological risk factors (n = 100) 35% 68% 42% 31% 3% NR
Genetic association (n = 50) 10% 96% 70% 54% 16% NR
Kirkham et al. 2010 [34] Cochrane
reviews of RCTs with well-defined
primary outcome (n = 283)
NR NR NR NR 7% NR
�Figures are unlikely to be directly comparable as criteria used by different studies vary widely
��The actual figure is likely to be higher as this did not include situations in which “publication bias was not assessed for some reason”.
NR: not reported.
https://doi.org/10.1371/journal.pone.0227580.t005
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meta-analytical approach in reviews of various types of clinical research).[38] Since generating
an overall estimate of a “true effect” is not the main focus, the issue of publication and outcome
reporting biases may be perceived as unimportant or irrelevant in reviews adopting configura-
tive approaches.
Furthermore, the diverse and context-specific nature of evidence in HSDR may have fur-
ther impeded formal assessment of publication bias. Funnel plots and related techniques, the
most commonly used methods, require that at least 10 studies of varied sample sizes that are
addressing sufficiently similar questions and that have used compatible outcome measures to
enable appropriate analyses [15]. In HSDR systematic reviews, the level of heterogeneity
among included studies are often high and so reviewers are often not able to use these formal
statistical techniques. Irrespective of the technical requirements, such statistical methods could
only detect small study effects, which could be suggestive of publication bias but do not prove
it, as several potential causes other than publication bias, such as issues related to study design,
statistical artefact and chance, could also lead to the presence of small study effects [15].
With the inherent limitations of statistical tools, the most reliable way to directly assess pub-
lication and outcome reporting biases is by following up studies from protocol registration to
see if the outcomes were subsequently published, as well as comparing the outcomes reported
in protocols to those eventually reported in output publications. Mandatory registration of
research protocols has been enforced among clinical studies on human subjects but not in
other fields. The lack of prospective registration of study protocols has been a major barrier for
evaluating publication and outcome reporting bias in HSDR as evidenced by the low preva-
lence of assessing these biases particularly among reviews of observational studies, e.g. 4%
among HSDR association reviews in our study and 7% among epidemiological risk factor
reviews examined by Song et al.[6]. Availability of pre-registered study protocols will poten-
tially safeguard against publication and outcome reporting biases and also enable reviewers to
assess those biases.
While pre-registration of study protocols is good research practice that should be encour-
aged irrespective of scientific disciplines, mandatory pre-registration of studies and their pro-
tocols in HSDR of different types of studies beyond clinical trials would require careful
deliberation and assessment with regard to feasibility and practical value, weighing potential
benefits against costs and potential harms. In the meantime, it is important to continue raising
awareness of these biases and improving the levels of documenting the awareness when evi-
dence from quantitative HSDR is synthesised. Our findings show that systematic reviews that
report the use of a systematic review guideline are five times more likely than those that don’t
to include an assessment of publication bias. Another study which evaluated the impact of the
PRISMA Statement on reporting in systematic reviews published in high-impact surgical jour-
nals reported that the proportion of systematic reviews which assessed publication bias was
significantly higher after the publication of PRISMA (53%) compared to before PRISMA
(39%) [32]. Methodological standards such as Cochrane Collaboration’s Methodological
Expectations of Cochrane Intervention Reviews (MECIR) and systematic reviews reporting
guidelines such as PRISMA and MOOSE [18] are therefore likely to play an important role.
Nevertheless, the sub-optimal level of documenting awareness found in this and other studies
highlight that additional mechanisms may be required to enforce them. For example, although
70% of the systematic reviews in this study are published in journals which endorse systematic
review guidelines, the use of such guidelines was only reported in 37% of the systematic
reviews. Journal editors and peer reviewers can help ensure that review authors adhere to rec-
ommended guidelines which will in turn promote the consideration of publication bias.
All the reviews which assessed outcome reporting bas in the current study did so as part of
quality assessment of individual studies, especially those that used the Cochrane risk of bias
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tool [26]. Outcome reporting bias is a standard item in the current Cochrane risk of bias tool
[26], which is most widely used in intervention reviews. However, this item is not included in
tools commonly used for assessing observational studies such as the Newcastle-Ottawa scale
[39]. This may contribute, in part, to the much higher proportion of intervention reviews that
assessed outcome reporting bias compared to association reviews. Given that the risk of out-
come reporting bias is substantially higher for observational studies, this is an important deficit
which developers of quality assessment tools for observational studies need to address in the
future.
Finally, the search and inclusion of grey/unpublished literature remain a potentially impor-
tant strategy in minimising the potential effect of publication bias. In this study, 52% of the
selected systematic reviews reported searching at least one source of grey literature. This is
comparable to that which was reported (64%) in a recent audit of systematic reviews published
in high ranking journals such as Journal of the American Medical Association, The British
Medical Journal, Lancet, Annals of Internal Medicine and the Cochrane Database of System-
atic Reviews [30]. The slightly higher value reported in the audit may be attributable to inclu-
sion of only high impact journals. Our study further showed that reviewers who searched for
grey literature do not necessarily assess/discuss the potential effect of publication bias. This
suggests some review authors might have followed the good practice of searching the grey/
unpublished literature to ensure comprehensiveness without considering minimising publica-
tion bias as a rationale behind this. Alternatively, these authors may consider a comprehensive
search as an ultimate strategy to mitigate potential publication bias and therefore deemed it
unnecessary to assess and/or discuss the potential impact of publication bias. However, review-
ers need to be aware that the search of grey literature alone is not enough to completely
alleviate publication bias and it is often impractical to search all possible sources of grey litera-
ture. There is limited evidence suggesting that the quality and nature of data included in
published HSDR studies differ from that included in grey literature [40]. Therefore, more
empirical evidence is needed to guide future practice regarding search of grey/unpublished lit-
erature, taking into account the trade-off between biases averted and additional resources
required.
Conclusion
Publication and outcome reporting biases are not consistently considered/assessed in HSDR
systematic reviews. Formal assessment of publication bias and outcome reporting biases may
not always be possible until a comprehensive registration of HSDR studies and their protocols
becomes available. Notwithstanding this, review authors could still consider and acknowledge
the potential implications of these biases on the findings. Adherence to existing systematic
review guidelines may improve the consistency in assessment of these biases. Including items
for outcome reporting bias in future quality assessment tools of observational studies would
also be beneficial. The findings of this study would enhance awareness of publication and out-
come reporting biases in HSDR systematic reviews and inform future systematic review meth-
odologies and reporting.
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